34
Views
50
CrossRef citations to date
0
Altmetric
Research Article

The ATM gene and the radiobiology of ataxia-telangiectasia

Pages 527-537 | Published online: 03 Jul 2009

References

  • ASTOR, M. B. and MORSE, T. D., 1989, Rapid repair of poten-tially lethal damage in normal and ataxia telangiectasia cell lines. International Journal of Radiation Biology, 55, 631–639.
  • BEAMISH, H., KHANNA, K. K. and LAVIN, M. F., 1994, Ionizing radiation and cell cycle progression in ataxia telangiectasia. Radiation Research, 138(suppl.), S130–133.
  • BEAMISH, H. and LAVIN, M. F., 1994, Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. International Journal of Radiation Biology, 65, 175–184.
  • BECKMAN, J. S., 1994, Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Annals of the New York Academy of Science, 738, 69–75.
  • BECKMAN, J. S., CHEN, J., CROW, J. P. and YE, Y. Z., 1994, Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Progress in Brain Research, 103, 371–380.
  • BIEDERMANN, K. A., SUN, J. R., GIACCIA, A. J., TOSTO, L. M. and Brown, J. M., 1991, scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proceedings of the National Academy of Science, USA, 88, 1394–1397.
  • BLOCHER, D., SIGUT, D. and HANNAN, M. A., 1991, Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. International Journal of Radiation Biology, 60, 791–802.
  • BoicE, J. D., Jr and MILLER, R. W., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1357–1358.
  • BOUFFLER, S. D., KEMP, C. J., BALMAIN, A. and Cox, R., 1995, Spontaneous and ionizing radiation-induced chromo-somal abnormalities in p53-deficient mice. Cancer Research, 55, 3883–3889.
  • BRIDGES, B. A. and ARLETT, C. F., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1357.
  • BROWN, E. J., ALBERS, M. W., SHIN, T. B., ICHIKAWA, K., KEITH, C. T., LANE, W. S. and SCHREIBER, S. L., 1994, A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature, 369, 756–758.
  • BROWN, E.J., BEAL, P. A., KEITH, C. T., CHEN, J., SHIN, T. B. and SCHREIBER, S. L., 1995, Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature, 377, 441-446. CIMPRICH, K. A., SHIN, T. B., KEITH, C. T., and SCHREIBER, S. L., 1996, cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proceedings of the National Academy of Sciences USA, 93, 2850–2855.
  • CLEETER, M. W., COOPER, J. M., DARLEY-USMAR, V. M., MONCADA, S. and SCHAPIRA, A. H., 1994, Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Impli-cations for neurodegenrative disease. FEBS Letters, 345, 50–54.
  • CORNFORTH, M. N. and BEDFORD, J. S., 1985, On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science, 227, 1589–1591.
  • CORNFORTH, M. N. and BEDFORD, J. S., 1987, A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiation Research, 111, 385–405.
  • DECKWERTH, T. L. and JOHNSON, E. M. Jr., 1993, Neurotrophic factor deprivation-induced death. Annals of the New York Academy of Science, 679, 121–131.
  • DIVECHA, N. and IRVINE, R. F., 1995, Phospholipid signaling. Cell, 80, 269–278.
  • DOWNWARD, J., 1995, Signal transduction: a target for PI(3) kinase. Nature, 376, 553–554.
  • EASTON, D. F., 1994, Cancer risk in A-T heterozygotes. Interna-tional Journal of Radiation Biology, 66(suppl.), S177–182.
  • EULOP, G. M. and PHILLIPS, R. A., 1990, The scid mutation in mice causes a general defect in DNA repair. Nature, 347, 479–482.
  • GATTI, R. A., BODER, E., VINTERS, H. V., SPARKES, R. S., NORMAN, A. and LANGE, K., 1991, Ataxia-telangiectasia: an interdis-ciplinary approach to pathogenesis. Medicine (Baltimore), 70, 99–117.
  • GILAD, S., KHOSRAVI, R., SHKEDY, D., UZIEL, T., ZIV, Y, SAVITSKY, K., ROTMAN, G., SMITH, S., CHESSA, L., JORGENSEN, T. J., HARNIK, R., ERYDMAN, M., SANAL, 0., pORTNOI, S., GOLDWICZ, Z., JASPERS, N. G.J., GATTI, R. A., LENOIR, G., LAVIN, M. F., TATSUMI, K., WEGNER, R. D., SHILOH, Y and BAR-SHIRA, A., 1996, Predominance of null mutations in ataxia-telangiectasia. Human Molecular Genetics, 5, 433–440.
  • GREENWELL, P. mr., KRONMAL, S. L., PORTER, S. E., GASSENHIJBER, J., OBERMAIER, B. and PETES, T. D., 1995, TEL1, a gene involved in controlling telemere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell, 82, 823–829.
  • HALL, E. J., GEARD, C. R. and BRENNER, D. J., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1358–1359.
  • HARI, K. L., SANTERRE, A., SEKELSKY, J. J., MCKIM, K. S., BOYD, J. B. and HAWLEY, R. S., 1995, The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell, 82, 815–821.
  • HARNDEN, D. G., 1994, The nature of ataxia-telangiectasia: Problems and perspectives. International Journal of Radiation Biology, 66 (suppl.), S13–19.
  • HARTLE K. 0., GELL, D., SMITH, G. C. M., ZHANG, H., DIVECHA, N., CONNELLY, M. A., ADMON, A., LEES-MILLER, S. P., ANDERSON, C. W. and JACKSON, S. P., 1995, DNA-dependent protein kinase catalytic subunit: A relative of phosphotidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell, 82, 849–856.
  • HARTWELL, L. H. and KASTAN, M. B., 1994, Cell cycle control and cancer. Science, 266, 1821–1828.
  • HENDRICKSON, E. A., QIN, X.-Q., BUMF., E. A., SCHATZ, D. G., °ETTINGER, M. and WEAVER, D. T., 1991, A link between double-strand break-related repair and V(D)J recom-bination: the scid mutation. Proceedings of the National Academy of Sciences, USA, 88, 4061–4065.
  • HEPPEL, A., BUTTERWORTH, S. V., HOLLIS, R. J., KENNAUGH, A. A., BEATTY, D. W. and TAYLOR, A. M. R., 1988, Breakage of the T cell receptor alpha chain locus in non-malignant clones from patients with ataxia-telangiectasia. Human Genetics, 79, 360–364.
  • HOULDSWORTH, J., COHEN, D., SINGH, S. and LAVIN, M. F., 1991, The response of ataxia-telangiectasia lymphoblastoid cells to neutron irradiation. Radiation Research, 125, 277–282.
  • HOULSWORTH, J. and LAVIN, M. F., 1980, Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia. Nucleic Acids Research, 8, 3709–3720.
  • HUNTER, T., 1995, When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell, 83, 1–4.
  • JASPERS, N. G. J. and BOOTSMA, D., 1982, Genetic heterogeneity in ataxia telangiectasia studied by cell fusion. Proceedings of the National Academy of Sciences, USA, 79, 2641.
  • JASPERS, N. G., PAINTER, R. B., PATERSON, M. C., KIDSON, C. and INouE, T., 1985, Complementation analysis of ataxia-telangiectasia. In: Ataxia-Telangiectasia: Genetics, Neuro-pathology and Immunology of a Degenerative Disease of Childhood. Edited by R. A. Gatti and M. Swift (New York: Alan R. Liss, Inc.), pp. 147–162.
  • KASTAN, M. B., ZHAN, Q., EL-DEIRY, W. S., CARRIER, F., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FOR-NACE, A. J., Jr, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71,587–597.
  • KEITH, C. T. and SCHREIBER, S. L., 1995, PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science, 270, 50–51.
  • KHANNA, K. K., BEAMISH, H., YAN, J., HOBSON, K., WILLIAMS, R., DUNN, I. and LAVIN, M. F., 1995, Nature of Gi/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene, 11, 609–618.
  • KIRCHGESSNER, C. U., PATIL, C. K., EVANS, J. W., CUOMO, C. A., FRIED, L. M., CARTER, T., °ETTINGER, M. A. and BROWN, J. M., 1995, DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science, 267, 1178–1183.
  • Kops, T. L., GATTI, R. A. and SPARKES, R. S., 1991, The cytogenetics of ataxia telangiectasia. Cancer Genetics and Cytogenetics, 56, 143–156.
  • KOMATSU, K., OKUMURA, Y., KODAMA, S., YOSHIDA, M. and MILLER, R. C., 1989, Lack of correlation between radio-sensitivity and inhibition of DNA synthesis in hybrids (A-T x HeLa). International Journal of Radiation Biology, 56, 863–867.
  • KULLER, L. H. and MODAN, B., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1357.
  • LAMBERT, W. C., KOLBER, L. R., GORELLI, L. A., MUGLIA, J. J. and KARDASHIAN, J. F., 1982, Epidermoid carcinoma of the oral cavity following diagnostic roentgenographic examination in a patient with ataxia-telangiectasia. Clinical Preventive Dentistry, 4, 3–8.
  • LAND, C. E., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1359–1360.
  • LAVIN, M. F. and SCHROEDER, A. L., 1988, Damage-resistant DNA synthesis in eukaryotes. Mutation Research, 193, 193–206.
  • LEE, J. M. and BERNSTEIN, A., 1993, p53 Mutations increase resistance to ionizing radiation. Proceedings of the
  • National Academy of Sciences, USA, 90, 5742–5746. LEES-MILLER, S. P., GODBOUT, R., CHAN, D. W., WEINFELD, M.,
  • DAY, R. S., III, BARRON, G. M. and ALLALUNIS-TURNER, J., 1995, Absence of p350 subunit of DNA-activated pro-tein kinase from a radiosensitive human cell line. Science, 267, 1183–1185.
  • LEHMANN, A. R., ARLETT, C. F., BURKE, J. F., GREEN, M. H. L., JAMES, M. R. and LOWE, J. E., 1986, A derivative of an ataxia-telangiectasia (A-T) cell line with normal radio-sensitivity but A-T-like inhibition of DNA synthesis. International Journal of Radiation Biology, 49, 639–643.
  • LINET, M. S., 1985, The Leukaemias: Epidemiologic Aspects (Oxford University Press, New York).
  • LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A. and JACKS, T., 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847–849.
  • Lu, X. and LANE, D. P., 1993, Differential induction of tran-scriptionally active p53 following UV or ionizing radia-tion: defects in chromosome instability syndromes? Cell, 75, 765–778.
  • MARTIN, D. P., Ho, A., HORIGOME, K., LAMPE, P. A. and JOHNSON, E. M. Jr, 1992, Biochemical characterization of pro-grammed cell death in NGF-deprived sympathetic neurons. Journal of Neurobiology, 23, 1205–1220.
  • METCALFE, J. A., HEPPELL-PARTON, A., MCCONVILLE, C. M. and TAYLOR, A. M. R., 1991, Characterization of a B-lympho-cyte t(2;14) (p11;q32) translocation from an ataxia telangiectasia patient conferring a proliferative advan-tage on cells in vitro. Cytogenetics and Cell Genetics, 56, 91–98.
  • MEYN, M. S., 1995, Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Research, 55, 5991–6001.
  • MEYN, M. S., STRASFELD, L. and ALLEN, C., 1994, Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. International Journal of Radiation Biology, 66 (suppl.), S141–149.
  • MILLER, R. D., HoGG, J., OzARI, J. H., GELL, D., JACKSON, S. P. and RIBLET, R., 1995, Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proceedings of the National Academy of Sciences, USA, 92, 10792–10795.
  • MIRZAYANS, R. and PATERSON, M. C., 1991, Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide. Carcinogenesis, 12, 19–24.
  • MORROW, D. M., TAGLE, D. A., SHILOH, Y, COLLINS, F. S. and HIETER, P., 1995, TEL1, an S. cerevisiaehomolog of the human gene mutated in ataxia telangiectasia, is func-tionally related to the yeast checkpoint gene MEC1. Cell, 82, 831–840.
  • MOUNT, H. T. J., DREYFUS, C. F. and BLACK, I. B., 1995, Purkinje cell survival is differentially regulated by metabotropic and ionotropic excitatory amino acid receptors. Journal of Neuroscience, 13, 3173–179.
  • MURNANE, J. P. and PAINTER, R. B., 1982, Complementation of the defects in DNA synthesis in irradiated andunirradiatedataxia-telangiectasiacells.Proceedings of the National Academy of Sciences, USA, 79, 1960–1963.
  • National Research Council Committee on the Biological Kojis, Effects of Ionizing Radiation, 1990, Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V) (National Academy Press, Washington).
  • PAINTER, R. B., 1986, Inhibition of mammalian cell DNA synthesis by ionizing radiation. International Journal of Radiation Biology, 49, 771–781.
  • PAINTER, R. B. and YOUNG, B. R., 1980, Radiosensitivity in ataxia-telangiectasia: a new explanation. Proceedings of the National Academy of Sciences, USA, 77, 7315–7317.
  • PANDITA, T. K. and HITTELMAN, W. N., 1994, Increased initial levels of chromosome damage and heterogeneous chromosome repair in ataxia telangiectasia hetero-zygote cells. Mutation Research and Fundamental Mechan-isms of Mutagenesis, 310, 1–13.
  • PANDITA, T. K., PATHAK, S. and GEARD, C. R., 1995, Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenetics and Cell Genetics, 71, 86–93.
  • PATERSON, M. C., MACFARLANE, S. J., GENTNER, N. E. and SMITH, B. P., 1985, Cellular hypersensitivity to chronic gamma-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes. In: A taxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood. Edited by R.A. Gatti and M. Swift. (Liss, New York), pp. 73–87.
  • PAULOVICH, A. G. and HARTWELL, L. H., 1995, A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell, 82, 841–847.
  • PETERSON, R. D. A. and FUNKHOUSER, J. D., 1989, Speculations on ataxia-telangiectasia: Defective regulation of the immunoglobulin gene superfamily. Immunology Today, 10, 313–315.
  • RUDOLPH, N. S., NAGASAWA, H., LITTLE, J. B. and LATT, S. A., 1989, Identification of ataxia telangiectasia heterozygotes by flow cytometric analysis of X-ray damage. Mutation Research, 211, 19–29.
  • SABATINI, D. M., ERDJUMENT-BROMAGE, H., Lui, M., TEMPST, P. and SNYDER, S. H., 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell, 78, 35–43.
  • SANAL, 0., BERKEL, A. I., ERSOY, F., TEZCAN, I. and TOPAGLU, H., 1993, Clinical variants of ataxia-telangiectasia. In: Ataxia Telangioectasia NATO ASI Series, Series H: Cell Biology, Vol. 77. Edited by R. A. Gatti and R. B. Painter. (Springer, Berlin), pp. 183–189.
  • SANFORD, K. K., PARSHAD, R., PRICE, F. M., JONES, G. M., TARONE, R. E., EIERMAN, L., HALE, P. and WALDMANN, T. A., 1990, Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. Journal of the National Cancer Institute, 82, 1050–1054.
  • SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., Zw, Y, VANAGAITE, L., TAGLE, D. A., SMITH, S., UZIEL, T., SEEZ, S., ASHKENAZI, M., PECKER, I., FRYDMAN, M., HARNIK, R., PATANJALI, S. R., SIMMONS, A., CLINES, G. A., SARTIEL, A., GATTI, R. A., CHESSA, L., SANAL, 0., LAWN, M. F., JASPERS, N. G. J. and SHILOH, Y, 1995a, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749–1753.
  • SAVITSKS K., SFEZ, S., TAGLE, D. A., ZnT, Y, SARTIEL, A., COLLINS, F. S., SHILOH, Y and ROTMAN, G., 1995b, The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Human Molecular Genetics, 4, 2025–2032.
  • SEATON, B. L., YUCEL, J., SUNNERHAGEN, P. and SUBRAMANI, S., 1992, Isolation and characterization of the Schizosac-charomyces pombe rad3 gene, involved in the DNA damage and DNA synthesis checkpoints. Gene, 119, 83–89.
  • SEDGWICK, R. P. and BODER, E., 1991, Ataxia-telangiectasia. In: Handbook of Clinical Neurology. Edited by P.J. Vinken, G. W. Bruyn and H. L. Klawans (Elsevier, New York), pp. 347–423.
  • SHERRINGTON, P. D., FISCH, p., TAYLOR, A. M. R. and RABBITTS, T. H., 1994, Clonal evolution of malignant and non-malignant T cells carrying t(14;14) and t(X;14) in patients with ataxia telangiectasia. Oncogene, 9, 2377–2381.
  • SHILOH, Y, 1995, Ataxia-telangiectasia: closer to unraveling the mystery. European Journal of Human Genetics, 3, 116–138.
  • SIPLEY, J. D., MENNINGER, J. C., HARTLEY, K. 0., WARD, D. C., JACKSON, S. P. and ANDERSON, C. W., 1995, Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromo-some 8. Proceedings of the National Academy of Sciences, USA, 92, 7515–7519.
  • SLEBos, R. J. C., LEE, M. H., PLUNKETT, B. S., KESSIS, T. D., WILLIAMS, B. 0., JACKS, T., HEDRICK, L., KASTAN, M. B. and CHo, K. R., 1994, p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proceedings of the National Academy of Sciences, USA, 91, 5320–5324.
  • SLICHENMYER, W. J., NELSON, W. G., SLEBOS, R. J. and KASTAN, M. B., 1993, Loss of a p53-associated G1 check-point does not decrease cell survival following DNA damage. Cancer Research, 53, 4164–4168.
  • SMITH, P. J. and PATERSON, M. C., 1983, Effect of aphidocolin on de novo DNA synthesis, DNA repair, and cytotoxicity in gamma-irradiated human fibroblasts: implications for the enhanced radiosensitivity in ataxia telangiectasia. Biochimica et Biophysica Acta, 739, 17–26.
  • STERN, M.-H., LIPKOWITZ, S., AURIAS, A., GRISCELLI, C., THOMAS, G. and KIRSCH, I. R., 1989, Inversion of chromosome 7 in ataxia telangiectasia is generated by a rearrangement between T-cell receptor tau genes. Blood, 6, 2076–2080.
  • STEWART, N., HICKS, G. G., PARASKEVAS, F. and MOWAT, M., 1995, Evidence for a second cell cycle block at G2/M by p53. Oncogene, 10, 109–115.
  • SWIFT, M., 1994, Ionizing radiation, breast cancer, and ataxia-telangiectasia. Journal of the National Cancer Institute, 86, 1571–1573.
  • SWIFT, M., 1995, Cancer mortality and low doses of ionising radiation. Lancet, 345, 253.
  • SWIFT, M., MORRELL, D., MASSEY, R. B. and CHASE, C. L., 1991, Incidence of cancer in 161 families affected by ataxia-telangiectasia. New England Journal of Medicine, 325, 1831–1836.
  • SWIFT, M., MORRELL, D., MASSEY, R. B. and CHASE, C. L., 1992, Risk of breast cancer in ataxia-telangiectasia. Reply. New England Journal of Medicine, 326, 1360–1361.
  • SWIFT, M., REITNAUER, p. J., MORRELL, D. and CHASE, C. L., 1987, Breast and other cancers in families with ataxia-telangiectasia. New England Journal of Medicine, 316, 1289–1294.
  • TACCIOLI, G. E., GOTTLIEB, T. M., BLUNT, T., PRIESTLEY, A., DEMENGEOT, J., MIZUTA, R., LEHMANN, A. R., ALT, F. W., JACKSON, S. P. and JEGGO, P. A., 1994, Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science, 265, 1442–1445.
  • TAKAI, S., SANFORD, K. K. and TARONE, R. E., 1990, A procedure for carrier detection in ataxia-telangiectasia. Cancer Genetics and Cytogenetics, 46, 139–140.
  • TAYLOR, A. M., FLUDE, E., LAHER, B., STACEY, M., MCKAY, E., WATT, J., GREEN, S. H. and HARDING, A. E., 1987, Variant forms of ataxia telangiectasia. Journal of Medical Genetics, 24, 669–677.
  • TAYLOR, A. M. R., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A., LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A., 1975, Ataxia telangiectasia: a mutation with abnormal radia-tion sensitivity. Nature, 258, 427–429.
  • TAYLOR, A. M. R., MCCONVILLE, C. M., ROTMAN, G., SHILOH, Y and BYRD, P. J., 1994, A haplotype common to intermediate radiosensitivity variants of ataxia-telangiectasia in the UK. International Journal of Radiation Biology, 66 (suppl.), S35–41.
  • TAYLOR, A. M. R., McCoNvILLE, C. M., WOODS, C. G., BYRD, P. J. and HERNANDEZ, D., 1993, Clinical and cellular hetero-geneity in ataxia telangiectasia. In: Ataxia Telangiectasia. NATO ASI Series: H, Vol. 77. Edited by R. A. Gatti and R. B. Painter (Springer, Berlin), pp. 209–234.
  • THICK, J., SHERRINGTON, P. D., FISCH, p., TAYLOR, A. M. R. and RABBITTS, T. H., 1992, Molecular analysis of a new translocation, t(X;14) (q28;q11), in a premalignancy and in leukaemia associated with ataxia telangiectasia. Genes, Chromosomes and Cancer, 5, 321–325.
  • THOMPSON, L. H. and JEGGO, P. A., 1995, Nomenclature of human genes involved in ionizing radiation sensitivity. Mutation Research, 337, 131–134.
  • WAGNER, L. K., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1358.
  • WALDMANN, T. A., BRODER, S., GOLDMAN, C. K., FROST, K., KORSMEYER, S. J. and MEDICI, M.A., 1983a, Disorders of B cells and helper T cells in the pathogenesis of immunoglobulin deficiency of patients with ataxia-telangiectasia. Journal of Clinical Investigations, 71, 282–295.
  • WALDmANN, T. A., MISITI, J., NELSON, D. L. and KRAEmER, K. H., 1983b, Ataxia-telangiectasia: A multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high inci-dence of neoplasia. Annals of Internal Medicine, 99, 367–379.
  • WEEKS, D. E., PATERSON, M. C., LANGE, K., ANDRAIS, B., DAVIS, R. C., YODER, F. and GATTI, R. A., 1991, Assessment of chronic gamma radiosensitivity as an in vitro assay for hetero-zygote identification of ataxia-telangiectasia. Radiation Research, 128, 90–99.
  • ZAKIAN, V. A., 1995, ATM-related genes: what do they tell us about functions of the human gene? Cell, 82, 685–687.
  • ZAMPETTI-BOSSELER, F. and SCOTT, D., 1981, Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibro-blasts after x-irradiation. International Journal of Radia-tion Biology, 5, 547–558.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.